Cite
Opportunities and Challenges of Observational Studies and Randomized Controlled Trials for Evaluating the Therapeutic Efficacy of COVID-19 Convalescent Plasma.
MLA
Lyman, Gary H., et al. “Opportunities and Challenges of Observational Studies and Randomized Controlled Trials for Evaluating the Therapeutic Efficacy of COVID-19 Convalescent Plasma.” Cancer Investigation, vol. 39, no. 6/7, July 2021, pp. 449–56. EBSCOhost, https://doi.org/10.1080/07357907.2021.1942127.
APA
Lyman, G. H., Desai, A., Leyfman, Y., & Kuderer, N. M. (2021). Opportunities and Challenges of Observational Studies and Randomized Controlled Trials for Evaluating the Therapeutic Efficacy of COVID-19 Convalescent Plasma. Cancer Investigation, 39(6/7), 449–456. https://doi.org/10.1080/07357907.2021.1942127
Chicago
Lyman, Gary H., Aakash Desai, Yan Leyfman, and Nicole M. Kuderer. 2021. “Opportunities and Challenges of Observational Studies and Randomized Controlled Trials for Evaluating the Therapeutic Efficacy of COVID-19 Convalescent Plasma.” Cancer Investigation 39 (6/7): 449–56. doi:10.1080/07357907.2021.1942127.